We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Attempts to Improve Biologics Reviews Through Electronic Filing
FDA Attempts to Improve Biologics Reviews Through Electronic Filing
October 20, 2006
CBER is increasing the use of electronic applications for new biologics to ensure more efficient, effective and consistent reviews, an agency official said.